Publication | Open Access

Multi-omics integrated circulating cell-free DNA genomic signatures enhanced the diagnostic performance of early-stage lung cancer and postoperative minimal residual disease

Nucleic Acid BiomarkersEarly-stage Lung CancerMedicineMulti-omics StudyPathologyCancer GenomicsBronchial NeoplasmOmicsDiagnostic PerformanceLung CancerMolecular DiagnosticsOncologyRadiation OncologyTumor Microenvironment